최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국임상약학회지 = Korean journal of clinical pharmacy, v.20 no.3, 2010년, pp.229 - 234
이경은 (보스턴메디컬센터)
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
American College of Rheumatology. Patient education for fibromyalgia. www.rheumatology.org/public/factsheets/diseases_and_conditions/fibromyalgia.asp?audpat (accessed July 25, 2010).
Wolfe F, Ross K, Anderson J, et al., The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19-28.
Kim SH, Bae GR, Lim HS. Prevalence and risk factors of fibromyalgia syndrome and chronic widespread pain in two communities in Korea - First report in Korean. J Korean Rheumatism Assoc 2006; 13: 18-25.
Wolfe F, Ross K, Anderson J, et al., Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 1995; 22: 151-6.
Navarro RP. Contemporary management strategies for fibromyalgia. Am J Manag Care 2009; 15: S197-218.
WolfeF, Smythe H, Yunus M, et al., The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160-172.
Bennett R. Fibromyalgia: present to future. CurrRheumatol Rep 2005; 7: 371-376.
Abeles AM, Pillinger MH, Solitar BM, et al., Narrative review:the pathophysiology of fibromyalgia. Ann Intern Med 2007; 146: 726-734.
Goldenberg DL. Pharmacological treatment of fibromyalgia and other chronic musculoskeletal pain. Best Pract Res ClinRheumatol 2007; 21: 499-511.
Abeles M, Solitar BM, Pillinger MH, et al., Update on fibromyalgia therapy. Am J Med 2008; 121: 555-561.
Savella. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc; expires 2010 Dec 31 (accessed July 26, 2010).
Forest Laboratories, Inc. Forest Laboratories, Inc. and Cypress Bioscience, Inc. announce commercial availability ofSavella. www.frx.com/news/ PressRelease. aspx/ (accessed July 26, 2010)
Jones CK, Eastwood BJ, Need AB, et al., Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: Evidence for synergism between serotonergic and noradrenergic reuptake inhibition. Neuropharmacology 2006; 51: 1172-1180.
Obata H, Saito S, Koizuka S, et al., The monoamine-mediated antiallodynic effects ofintrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a rat model of neuropathic pain. AnesthAnalg 2005; 100: 1406-1410.
Product information. Savella (milnacipran). New York, NY: Forest Pharmaceuticals, Inc., December 2009.
Puozzo C. Lens S, Reh C, et al., Lack of interaction of milnacipran with the cytochrome P450 isoenzymes frequently involved in the metabolism of antidepressants. ClinPharmacokinet 2005; 44: 977-988.
Puozzo C, Panconi E, Deprez D. Pharmacology and pharmacokinetics of milnacipran. IntClinPsychopharmacol 2002; 17(Suppl 1): S25-S35.
Vaishnavi SN, Nemeroff CB, Plott SJ, et al., Milnacipran: A comparative analysis of human monoamine uptake and transporter binding affinity. Biol Psychiatry 2004; 55: 320-322.
Gendreau RM, Thorn MD, Gendreau JF, et al., Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 2005; 32: 1975-1985.
Clauw DJ, Mease P, Palmer RH, et al., Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clnical trial. ClinTher 2008; 30: 1988-2004.
Mease PJ, Clauw DJ, Gendreau RM, et al., The efficacy and safety of milnacipran for the treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol 2009; 36: 398-409.
Goldenberg DL, Clauw DJ, Palmer RH, et al., Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study. Pain Med 2010; 11: 180-194.
Arnold LM, Gendreau RM, Palmer RH, et al., Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2010; 62: 2745-2756.
Branco JC, Zachrisson O, Perrot S, et al., A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia. J Rheumaol 2010; 37: 851-9.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.